$5.53B
$2.5 Million
0.02% of portfolio
24,137
Q4 2024
New
$940M
$3.32 Million
0.02% of portfolio
104,691
Q4 2024
New
$3.91B
$3.37 Million
0.02% of portfolio
162,905
Q4 2024
Added 82.61%
$1.54B
$3.34 Million
0.02% of portfolio
153,400
Q4 2024
New
$77.4B
$2.36 Million
0.02% of portfolio
24,975
Q4 2024
Reduced 88.5%
$1.3B
$2.99 Million
0.02% of portfolio
420,384
Q4 2024
Added 105.29%
$3.49B
$3.42 Million
0.02% of portfolio
489,000
Q4 2024
Reduced 29.63%
$1.43B
$2.43 Million
0.02% of portfolio
80,634
Q4 2024
Reduced 17.57%
$19.5B
$2.48 Million
0.02% of portfolio
187,464
Q4 2024
New
$48.4B
$2.63 Million
0.02% of portfolio
19,771
Q4 2024
Reduced 70.25%
$6.73B
$2.2 Million
0.02% of portfolio
90,810
Q4 2024
Added 138.33%
$29B
$2.6 Million
0.02% of portfolio
3,731
Q4 2024
Reduced 30.34%
$13.4B
$3.06 Million
0.02% of portfolio
22,873
Q4 2024
Reduced 94.8%
$1.21B
$2.41 Million
0.02% of portfolio
138,689
Q4 2024
Reduced 59.63%
$509M
$2.52 Million
0.02% of portfolio
120,792
Q4 2024
New
$0
$2.39 Million
0.02% of portfolio
13,617
Q4 2024
New
$3.47B
$3.28 Million
0.02% of portfolio
112,991
Q4 2024
Reduced 18.83%
$57.1B
$2.45 Million
0.02% of portfolio
31,032
Q4 2024
Added 63.77%
$5.27B
$2.81 Million
0.02% of portfolio
42,743
Q4 2024
New
$2.29B
$3.11 Million
0.02% of portfolio
54,886
Q4 2024
Reduced 83.52%
Kiniksa Pharmaceuticals Intl
-
$2.52 Million
0.02% of portfolio
-
Q4 2024
Added 965.18%
$486M
$2.59 Million
0.02% of portfolio
297,234
Q4 2024
Added 440.71%
$1.67B
$2.38 Million
0.02% of portfolio
54,646
Q4 2024
New
$4.09B
$2.75 Million
0.02% of portfolio
911,380
Q4 2024
New
$1.37B
$2.86 Million
0.02% of portfolio
444,599
Q4 2024
Added 421.84%
$2.64B
$2.58 Million
0.02% of portfolio
153,799
Q4 2024
New
$9.85B
$3 Million
0.02% of portfolio
22,035
Q4 2024
New
$669M
$2.39 Million
0.02% of portfolio
60,757
Q4 2024
Added 57.0%
$5.96B
$3.61 Million
0.02% of portfolio
21,796
Q4 2024
New
$4.63B
$3.13 Million
0.02% of portfolio
39,497
Q4 2024
Added 73.54%
$1.79B
$2.25 Million
0.02% of portfolio
168,960
Q4 2024
New
$1.99B
$3.1 Million
0.02% of portfolio
255,617
Q4 2024
New
Newbury Str Ii Acquisition C
-
$2.5 Million
0.02% of portfolio
-
Q4 2024
New
$1.98B
$2.19 Million
0.02% of portfolio
170,909
Q4 2024
New
$10.4B
$2.43 Million
0.02% of portfolio
88,347
Q4 2024
Reduced 69.12%
$3.38B
$2.41 Million
0.02% of portfolio
143,300
Q4 2024
Added 212.17%
$619M
$2.69 Million
0.02% of portfolio
334,146
Q4 2024
New
Oaktree Acquisition Corp Iii
-
$2.99 Million
0.02% of portfolio
-
Q4 2024
New
$1.38B
$2.78 Million
0.02% of portfolio
139,637
Q4 2024
Reduced 0.04%
$2.28B
$2.56 Million
0.02% of portfolio
190,150
Q4 2024
New
$80.9B
$3.17 Million
0.02% of portfolio
4,986
Q4 2024
Reduced 34.89%
$10.6B
$3.21 Million
0.02% of portfolio
16,101
Q4 2024
Added 470.76%
$18.6B
$2.84 Million
0.02% of portfolio
98,054
Q4 2024
New
$6.72B
$3.43 Million
0.02% of portfolio
29,964
Q4 2024
New
$2.24B
$3.59 Million
0.02% of portfolio
169,458
Q4 2024
Added 408.44%
$751M
$3.32 Million
0.02% of portfolio
356,038
Q4 2024
Added 53.21%
$668M
$3.42 Million
0.02% of portfolio
140,986
Q4 2024
Added 301.91%
$38.7B
$2.54 Million
0.02% of portfolio
8,041
Q4 2024
New
$10B
$2.59 Million
0.02% of portfolio
194,361
Q4 2024
Reduced 23.69%
$640M
$2.39 Million
0.02% of portfolio
189,879
Q4 2024
Added 189.37%